New Releases from NCBI BookshelfTofacitinib: Reimbursement Recommendation [Internet].​Tofacitinib: Reimbursement Recommendation [Internet].

The Formulary Management Expert Committee (FMEC) recommends that tofacitinib be reimbursed for the treatment of patients with juvenile idiopathic arthritis (JIA) provided certain conditions are met.

​ 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top